Molecular simulation study of CYP2B6 polymorphism with and without psoralen

被引:0
|
作者
Lu, Nan [1 ,2 ]
Meng, Fancui [3 ]
Xu, Weiren [3 ]
Tang, Lida [3 ]
Xu, Youjun [1 ,2 ]
机构
[1] Shenyang Pharmaceut Univ, Sch Pharmaceut Engn, Shenyang, Liaoning, Peoples R China
[2] Shenyang Pharmaceut Univ, Key Lab Struct Based Drug Design & Discovery, Shenyang, Liaoning, Peoples R China
[3] Tianjin Inst Pharmaceut Res, Tianjin Key Lab Mol Design & Drug Discovery, Tianjin, Peoples R China
关键词
CYP2B6; psoralen; molecular dynamics; molecular docking; mechanism-based inactivation; MECHANISM-BASED INACTIVATION; SINGLE NUCLEOTIDE POLYMORPHISM; CYTOCHROMES P450; FUNCTIONAL-CHARACTERIZATION; ALLELIC VARIANTS; STRUCTURAL BASIS; IN-SILICO; ACTIVATION; INHIBITION; EXPRESSION;
D O I
10.1080/08927022.2018.1513646
中图分类号
O64 [物理化学(理论化学)、化学物理学];
学科分类号
070304 ; 081704 ;
摘要
CYP2B6 is a polymorphic enzyme with a large number of variants which may lead to functional changes in enzyme activity and substrate selectivity. In this study, CYP2B6 and its three variants with and without psoralen, a mechanism-based inactivator, were investigated using molecular simulation method. The obtained docking orientation of psoralen was in agreement with previously identified site of metabolism. Stability analysis showed that the three variants displayed more flexibility than CYP2B6.1, and CYP2B6.34 was the most flexible one without psoralen binding. However, in the presence of psoralen, CYP2B6.34 became more rigidity. Tunnel analysis indicates that the bottleneck change of tunnels may be correlated to the increased or decreased activity of variants. Binding free energy analysis shows that van der Waals interaction dominates the binding of psoralen. CYP2B6.34 has the highest affinity to psoralen with lowest binding free energy. Ile114, Phe115 and heme contribute largely to the binding of psoralen with CYP2B6.6, while Phe206 and Leu363 play important roles for CYP2B6.1 and CYP2B6.4. These computational observations suggest that the increased activity of CYP2B6.4 and reduced activity of CYP2B6.6 may be due to changes in regional structures.
引用
收藏
页码:1402 / 1410
页数:9
相关论文
共 50 条
  • [21] CYP2B6 allelic variants and non-genetic factors influence CYP2B6 enzyme function
    Katalin Mangó
    Ádám Ferenc Kiss
    Ferenc Fekete
    Réka Erdős
    Katalin Monostory
    Scientific Reports, 12
  • [22] Bioactivation of chlorpyrifos by CYP2B6 variants
    Crane, Alice L.
    Klein, Kathrin
    Olson, James R.
    XENOBIOTICA, 2012, 42 (12) : 1255 - 1262
  • [23] Population Differences in the Genetic Polymorphism of CYP2B6 May Impact on the Pharmacology of MMT
    Nurfadhlina, M.
    Nasir, M.
    Darussalam, B.
    Azhar, M. Y. M.
    Tan, S. C.
    Ismail, R.
    PUBLIC HEALTH GENOMICS, 2015, 18 : 12 - 12
  • [24] Allele and genotype frequencies of CYP2B6 gene*5 polymorphism in a Turkish population
    Suzen, S.
    Artun, N. Y.
    TOXICOLOGY LETTERS, 2016, 258 : S78 - S79
  • [25] CYP2B6 18492T→C Polymorphism Compromises Efavirenz Concentration in Coinfected HIV and Tuberculosis Patients Carrying CYP2B6 Haplotype*1/*1
    Manosuthi, Weerawat
    Sukasem, Chonlaphat
    Thongyen, Supeda
    Nilkamhang, Samruay
    Manosuthi, Sukanya
    Sungkanuparph, Somnuek
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2014, 58 (04) : 2268 - 2273
  • [26] Synergism between CYP2B6 gene polymorphism and pxr-mediated induction
    Li, Haishan
    Wang, Hongbing
    DRUG METABOLISM REVIEWS, 2009, 41 : 31 - 32
  • [27] CYP2B6 GENETIC VARIATION AND EFAVIRENZ AUTOINDUCTION INFLUENCES CYP2B6 A ACTIVITY AND EFAVIRENZ EXPOSURE IN HEALTHY VOLUNTEERS
    Metzger, I. F.
    Lu, J. B.
    Kreutz, Y.
    Thong, N.
    Flockhart, D. A.
    Desta, Z.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2013, 93 : S80 - S80
  • [28] Haplotypes frequencies of CYP2B6 in Malaysia
    Musa, N.
    Zulkafli, M., I
    Talib, N.
    Mohamad, N.
    Fauzi, H.
    Ismail, R.
    JOURNAL OF POSTGRADUATE MEDICINE, 2012, 58 (04) : 235 - 241
  • [29] Involvement of CYP2D6 and CYP2B6 on tramadol pharmacokinetics
    Saiz-Rodriguez, Miriam
    Ochoa, Dolores
    Roman, Manuel
    Zubiaur, Pablo
    Koller, Dora
    Mejia, Gina
    Abad-Santos, Francisco
    PHARMACOGENOMICS, 2020, 21 (10) : 663 - 675
  • [30] DEC1 negatively regulates CYP2B6 expression by binding to the CYP2B6 promoter region ascribed to IL-6-induced downregulation of CYP2B6 expression in HeLa cells
    Luan, Xiaofei
    Zhao, Yi
    Bu, Na
    Chen, Yue
    Chen, Nan
    XENOBIOTICA, 2021, 51 (12) : 1343 - 1351